Nihon Pharmaceutical Co., Ltd.

Japon

 
Quantité totale PI 21
Rang # Quantité totale PI 70 455
Note d'activité PI 1,4/5.0    5
Rang # Activité PI 195 827
Parent Takeda Pharmaceutical Company Limited
Classe Nice dominante Produits chimiques destinés à l'...

Brevets

Marques

4 0
0 0
16 1
0
 
Dernier brevet 2024 - Composition for improving or mai...
Premier brevet 1990 - Composition for human cell culti...
Dernière marque 2021 - PCT II
Première marque 2021 - PCT II

Industrie (Classification de Nice)

Derniers inventions, produits et services

2023 Invention Composition for improving or maintaining muscle amount or muscle strength. The present invention ...
2021 P/S Collagen; collagen for industrial purposes; collagen used for manufacture of nutritional supplem...
2019 Invention Pharmaceutical composition. Provided is an oral intestinal tract cleansing agent which reduces th...
Invention Composition containing plasmalogen for enhancing memorization ability. This is to provide a usef...
Invention Plasmalogen-containing composition for increasing memorization ability. Provided is a useful but ...
2018 Invention Pharmaceutical composition, method for stabilisng pharmaceutical composition, and method for eval...
Invention Agent for the prevention or treatment of hepatic fibrosis disease. Provided is an agent for the p...
Invention Methods for producing compositions containing plasmalogen. Provided is a method for producing a c...
Invention Method for producing plasmalogen-containing composition. Provided is a method for producing a com...
Invention Portal vein thrombosis therapeutic agent. [Problem]To provide a novel technique, which is more ef...
Invention Drug for inhibiting histone-mediated cytotoxicity. Provided is a drug that can effectively inhibi...
2012 Invention Submucosal cushioning agent. In order to improve the resection efficiency, operability, and safet...
Invention Fusion protein. Provided is a novel fusion protein, which can specifically suppress an autoantibo...
2011 Invention Composition for treatment of aesthenopia. This is to provide a novel medicine and a food and a dr...
Invention Composition for the treatment of aesthenopia. Disclosed are a novel drug and a food or drink comp...
Invention Prophylactic or therapeutic agent for inflammatory bowel diseases or autoimmune peripheral neurop...
2010 Invention Smooth muscle contraction inhibitors. An emulsion comprising L-Menthol, a fat or oil and a surfac...
Invention Agent for the prevention or treatment of inflammatory bowel disease. Disclosed is an agent for th...
Invention Autoantibody production inhibitor. The present invention provides an autoantibody production inh...
Invention Autoantibody production inhibitor. Disclosed is an autoantibody production inhibitor which can in...
2009 Invention Menthol-containing formulation. It is known that L-menthol controls smooth muscle contraction. In...
2008 Invention Prophylactic/therapeutic agent for articular rheumatism. [PROBLEMS] The object is to provide a pr...
Invention Therapeutic agent for acute hepatitis or prophylactic/therapeutic agent for fulminant hepatitis. ...
Invention Remedy for acute hepatitis or preventive/remedy for fulminant hepatitis. [PROBLEMS] In the case w...
2004 Invention Menthol-containing preparation. It is known that L-menthol controls smooth muscle contraction. I...
Invention Menthol-containing preparation. It is known that L-menthol soothes smooth muscle motility. In ord...
2003 Invention Smooth muscle peristole inhibitor. An emulsion comprising L-Menthol, a fat or oil and a surfactan...
Invention Oil-in-water emulsion of l-menthol. Although an emulsion prepared by emulsifying l-menthol with a...
Invention Smooth muscle peristole inhibitor. An emulsion comprising L-menthol, a fat or oil and a surfactan...
1990 Invention Composition for human cell cultivation and use thereof. Abstract of the disclosure The pre...